Merrimack Pharmaceuticals Price on June 16, 2023

MACKDelisted Stock  USD 11.96  0.12  1.01%   
If you're considering investing in Merrimack Stock, it is important to understand the factors that can impact its price. As of today, the current price of Merrimack Pharmaceuticals stands at 11.96, as last reported on the 12th of December 2024, with the highest price reaching 12.01 and the lowest price hitting 11.84 during the day. We have found twenty-three technical indicators for Merrimack Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Merrimack Pharmaceuticals' Mean Deviation of 0.7806, standard deviation of 1.12, and Risk Adjusted Performance of (0.03) to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Merrimack Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
MACK
Based on monthly moving average Merrimack Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Merrimack Pharmaceuticals by adding Merrimack Pharmaceuticals to a well-diversified portfolio.

Merrimack Pharmaceuticals Valuation on June 16, 2023

It is possible to determine the worth of Merrimack Pharmaceuticals on a given historical date. On June 16, 2023 Merrimack was worth 12.36 at the beginning of the trading date compared to the closed value of 12.46. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Merrimack Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Merrimack Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Merrimack Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Merrimack Pharmaceuticals' related companies.
 Open High Low Close Volume
  12.42    12.52    12.30    12.39    134,502  
06/16/2023
  12.36    12.52    12.36    12.46    81,250  
  12.40    12.54    12.36    12.44    55,110  
Backtest Merrimack Pharmaceuticals  |  Merrimack Pharmaceuticals History  |  Merrimack Pharmaceuticals Valuation   PreviousNext  
Open Value
12.36
12.46
Closing Value
12.36
Upside

Merrimack Pharmaceuticals Trading Date Momentum on June 16, 2023

On June 20 2023 Merrimack Pharmaceuticals was traded for  12.44  at the closing time. The top price for the day was 12.54  and the lowest listed price was  12.36 . The trading volume for the day was 55.1 K. The trading history from June 20, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.16% . The trading delta at closing time against the current closing price is 1.20% .

Merrimack Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Merrimack Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Merrimack Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Merrimack financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Merrimack Pharmaceuticals Stock history

Merrimack Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Merrimack is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Merrimack Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Merrimack Pharmaceuticals stock prices may prove useful in developing a viable investing in Merrimack Pharmaceuticals
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts. Merrimack Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.

Merrimack Pharmaceuticals Stock Technical Analysis

Merrimack Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Merrimack Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Merrimack Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Merrimack Pharmaceuticals Period Price Range

Low
December 12, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Merrimack Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Merrimack Pharmaceuticals December 12, 2024 Market Strength

Market strength indicators help investors to evaluate how Merrimack Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Merrimack Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Merrimack Pharmaceuticals stock market strength indicators, traders can identify Merrimack Pharmaceuticals entry and exit signals to maximize returns

Merrimack Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Merrimack Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Merrimack Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Merrimack to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Merrimack Stock

If you are still planning to invest in Merrimack Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Merrimack Pharmaceuticals' history and understand the potential risks before investing.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Valuation
Check real value of public entities based on technical and fundamental data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm